Article
Epsin2, a novel target for multiple system atrophy therapy via α-synuclein/FABP7 propagation
21 Apr 2023
Abstract excerpt
Multiple system atrophy (MSA) is a neurodegenerative disease characterized by the accumulation of misfolded α-synuclein (αSyn) and myelin disruption. However, the mechanism underlying αSyn accumulation in MSA brains remains unclear. Here, we aimed to identify epsin-2 as a potential regulator of αSyn propagation in MSA brains. In the MSA mouse model, PLP-hαSyn mice, and FABP7/αSyn hetero-aggregate-injected mice,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
